# A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

> **NCT01222117** · PHASE2 · COMPLETED · sponsor: **Grifols Therapeutics LLC** · enrollment: 174 (actual)

## Conditions studied

- Acute Peripheral Arterial Occlusion

## Interventions

- **BIOLOGICAL:** Plasmin
- **BIOLOGICAL:** Plasminogen Activator
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01222117
- **Lead sponsor:** Grifols Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2017-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222117, "A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01222117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*